Skip to content

Understanding schemamodi by drawings

Understanding schemamodi by drawings

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25561
Enrollment
64
Registered
2015-10-19
Start date
2016-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schemamodi drawings Schemamodi getekende modiplaten

Interventions

Treatment contains four individual sessions in four weeks, one session a week. Each session has a duration of forty-five minutes. During the first session, there is an acquaintance with the therapist

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The current study was developed to evaluate the effect of the modi drawings on treatment outcome. We hypothesize that patients within the art modi group have more knowledge of their modi, which in turn will lead to a better understanding of ¡°why they act as they do¡±. During the first phase of ST (diagnostic and psycho-educational phase of ST) a therapeutic relationship will be built. Additionally information that will result in a schema modi conceptualization will be acquired (Young, Klosko, & Weishaar, 2005). We also hypothesize that the therapeutic alliance increases when participants feel their therapist understands them in the therapeutic sessions.

Exclusion criteria

Exclusion criteria: Exclusion criteria are intoxication by drugs or alcohol and severe depression as measured with the Beck Depression Inventory (BDI ¡Ý 30).

Design outcomes

Primary

MeasureTime frame
We expect that the patient within the experimental group, will have a better understanding of their modi, and therefore also of their behavioral patterns underlying their PDs, due to the visualization of the different modi.

Contacts

Public ContactIngrid Leenders-van Loo

Julianastraat 23 A

Leenders@u-center.nltel: +31-434559109

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)